NOTCH1 and acute lymphoblastic leukemia: Moreover, bortezomib, a proteasome inhibitor that exerted its antileukemic action through Notch1 transcriptional downregulation, was highly synergistic with dexamethasone in cellular and murine xenograft models of glucocorticoid-resistant T-ALL [382].